Blog / News

Wisconsin Governor’s Business Plan Contest - UPDATE

Angio360 moves on to Phase III of the Wisconsin Governor's Business Plan Contest!  

At the begining of the competition, there were a total of 206 teams - 27 have moved onto Phase III.  We will now submit a full 15-20 page business plan to be judged by a panel of more than 100 judges. 

See the link below for more information.


Wisconsin Governor’s Business Plan Contest

Angio360 was selected to move on to Phase II of the Wisconsin Governor’s Business Plan Contest!  There were a total of 206 contestants, 53 of which moved onto the second phase.  During phase II, Angio360 will submit a 1,000 word Executive Summary to be reviewed by a panel of judges who will select approximately 20 teams for phase III of the Contest.  In phase III, contestants will submit a full 15-20 page business plan. 

As a company, we are excited to be a part of this amazing challenge and surrounded by some of Wisconsin’s best and brightest.  Indeed, 2016 is shaping up to be an exciting year for us.  Stay tuned!    

See the link below for more information regarding the Contest.

Angio360 named Milwaukee company to watch in 2016

In an article posted in the Milwaukee Journal Sentinel online (December 23, 2015) by Matt Cordio of Startup Milwaukee, Angio360 was listed as one of six Milwaukee early stage companies to watch in 2016.

The five other companies listed in the article included Bright Cellars, GETTER, Rent College Pads, Tai Diagnostics (another MCW startup), and Wantable. We are very excited to be a part of this elite group of companies and look forward to working closely with the Milwaukee startup community in the coming years. 

One of the things we love the most about being based in Milwaukee is the strong sense of comradery and enthusiasm we find in the startup world.  The desire to help each other succeed is on full display and there is no shortage of support, advice, and general willingness to help.  We can only hope this sentiment continues to grow and foster new ideas with the potential to change the world.   

Congratulations to all and best of luck in 2016!

Commercial Evaluation License

Angio360 secures Commercial Evaluation License from the NIH

We are excited to announce that Angio360 successfully obtained a Commercial Evaluation License from the NIH of patents related to the detection of pathological angiogenesis and cancer.  We are very pleased that the NIH believes in our ability to bring a much needed cancer diagnostic test to the market.  Although this was a significant milestone for us, we are already looking forward to testing our proof of concept.  We have high hopes that these tests will not only solidify our path moving forward, but also provide important information regarding our product development. 


Angio360 in the News wrote about the Neuro Startup Challenge winners and highlighted Angio360.

We also note that PICO got a shout out too!  PICO, which stands for Postdoc Industry Consultants, is a group of postdocs that consult for local biotech companies and is where most of the co-founders first got their feet wet in biotech business.

We are grateful for the press and hope there will be more to come!

Layout Style


Predefined Colors